J Frank Harmon insider trades: Abraxis BioScience (ABBI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where J reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2007 | ABBI | ↓ Sell | 5,000 | $20.85 | $104K | Direct | Aug 15, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About J Frank Harmon's insider trades
J Frank Harmon is COO of Abraxis Phar. Prod Div. at Abraxis BioScience (ABBI). Since Aug 13, 2007, J has reported no open-market purchases and 1 sale worth $104K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares returned to the company (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABBI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.